All these observations suggest that modulating innate immune responses related to sterile inflammation will enable the development of the novel innovative approaches for the treatment of psychiatric disorders targeting ATP-Nlrp3 inflammasome-ComC axis. Here, ATP8A2 is linked to psychiatric disorder.